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SummARy – The authors investigated trends in the Croatian primary Percutaneous Coro-
nary intervention (pPCi) network results among three consecutive time intervals (2005-2007, first 
phase; 2008-2009, second phase; and 2010-2011, third phase). data on 5650 patients with acute 
myocardial infarction with ST-elevation (STemi) transferred or directly admitted and treated with 
pPCi in 11 Croatian PCi centers during the study period were collected and analyzed. The number 
of patients with acute STemi treated with pPCi per year rose continuously during the study period 
(581 vs.1272 vs. 1949 patients/year). The patient risk profile worsened during the study period: age 
(60 vs. 61 vs. 63 years; p<0.01), anterior myocardial wall involvement (43% vs. 44% vs. 51%; p<0.01), 
shock rate (7% vs. 9% vs. 11%; p<0.05), and percentage of transferred patients (42% vs. 36% vs. 46%; 
p<0.01). while the door-to-balloon time shortened (108 vs. 98 vs. 75 min; p<0.01), the symptom 
onset-to-door time increased (130 vs. 175 vs. 195 min; p<0.01), but without statistically significant 
influence on the total ischemic time. multivariate log-linear analysis eliminated influence of a higher 
risk profile on the results of treatment and yielded no statistically significant changes in final Timi 
3 flow (Thrombolysis in myocardial infarction 3), in-hospital mortality, and six-month mortality 
rate, but revealed a significant increase in the rate of angina pectoris (12 vs. 22 vs. 36%; p<0.01) and 
other major adverse cardiovascular events (mACe; 6 vs. 23 vs. 14%; p<0.01) during follow up. in 
conclusion, the Croatian pPCi network continuously ensures very good results of STemi treat-
ment in this economically less developed european country despite worsening of the risk profile in 
treated patients and opening of new, less experienced PCi centers. The higher percentage of mACe 
over time could be explained by changes in the pPCi strategy introduced over time (the culprit le-
sion only) and higher availability of PCi centers for additional PCi after acute STemi. however, 
there is room for improvement, especially in reducing prehospital delay.
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Introduction
Acute myocardial infarction (Ami) and its con-
sequences (death, chronic ischemic cardiac disease 
and heart failure) are the leading cause of death and 
cardiovascular diseases in developed world. in this 
context, patients with acute ST-elevation myocardial 
infarction (STemi) are at the highest risk. The first-
line management of STemi patients often deter-
mines whether the outcome will be survival or death1. 
An integrated network for the management of STe-
mi allows for early diagnosis and facilitates use of the 
best strategy to provide the most effective reperfusion 
therapy2. in acute coronary syndromes, timely PCI is a 
life-saving procedure with favorable long-term prog-
nosis, especially in the setting of STemi3,4. Adher-
ence to evidence based guidelines, assessed by mea-
suring key indicators, allows detecting, evaluating and 
improving the quality of care5. 
The incidence and mortality rates of Ami (STe-
mi in particular) are in decline or have remained 
stable in western world in the last ten years, probably 
owing to a combination of lifestyle changes, particu-
larly smoking cessation, and improved pharmacologi-
cal and interventional treatment. however, different 
results come from developing countries, where there 
is still up to 20% increase in STemi hospitalization 
every year5-11. Furthermore, Glickman et al.12 from 
the uSA claim that initiation of a statewide STEMI 
collaborative care model was associated with a reduc-
tion in mortality rates, but these changes were similar 
to those seen nationally, and that further studies are 
needed to evaluate the influence of such systems on 
the population-based STEMI outcomes.
The Croatian Primary PCi (pPCi) network was 
introduced in the mid-2005. The main goal was to 
achieve equal quality of treatment for acute STemi in 
all parts of Croatia. The principles of the network are 
as follows: 1) step-by-step implementation principle 
(presentation of the problem to the authorities, media 
campaign, extension of primary PCi up to 150 km 
away from the largest cities of Zagreb and Rijeka in 
the first year, and after that extension of the network 
to the entire Croatia, incorporation in the healthcare 
system of the Republic of Croatia); 2) proportional al-
location of PCi centers in all parts of Croatia; and 
3) continuous mutual communication among all par-
ticipants (meetings, educational courses, evaluation). 
After its establishment, first results of this network 
were internationally recognized as an example of well-
organized PCi network in an economically less devel-
oped country14-17.
Studies that evaluate trends in the results of such 
network development over a longer period of time are 
lacking in the literature. That is why the main goal of 
this investigation was to evaluate trends in the Croa-
tian pPCi network results achieved during seven 
years of its development. The main hypothesis was 
that over time, the pPCi network would enable very 
good results of acute STemi treatment for clinically 
and geographically wider groups of patients. 
Patients and Methods
The study included data on 5650 acute STemi pa-
tients treated with primary PCi within the Croatian 
pPCi network. Because of discontinuous retrograde 
register that exists in Croatia, the study period was di-
vided into three intervals: first phase from September 
1, 2005 to August 31, 2007; second phase from Janu-
ary 1, 2008 to december 31, 2009; and third phase 
from november 1, 2010 to november 1, 2011. Study 
patients were treated at eight PCi centers in the first 
phase, two new centers were introduced in the second 
phase, and one center in the third phase, so there were 
11 PCi centers in all parts of Croatia (five with and 
six without on-site cardiac surgery) at the end of the 
study. in the first, second and third phase of investi-
gation, 1161, 2543 and 1946 STemi patients were 
studied, respectively.
in all study patients, acute STemi was diagnosed 
in one of the centers with on-site PCi laboratory (cath-
eterization laboratory, cath-lab), where primary PCi 
was performed (non-transferred patients), or in hos-
pitals without on-site cath-lab, so they were urgently 
transferred to PCi centers for pPCi (transferred pa-
tients). The diagnosis of STemi was established and 
primary PCi performed using the then actual criteria 
of the european Cardiac Society18-21. in brief, patients 
with an episode of chest discomfort within the last 12 
hours and ST-elevation on eCG in at least two con-
tiguous leads were included. The patients received the 
loading dose of 300 mg salicylic acid, 600 mg clopi-
dogrel, intraprocedurally 70-100 ie/kg of unfraction-
ated heparin, and, according to judgment of the inter-
ventional cardiologist, a GPiib/iiia inhibitor.
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After pPCi, patients were hospitalized for 2 to 3 
days on average in coronary care units at PCi centers 
with continuous monitoring and treatment. After 
that, they finished their hospital treatment at car-
diac departments of those hospitals (non-transferred 
patients), or they were transferred back to their 
county hospitals (transferred patients). during their 
first hospital stay, general information (name, age 
and gender) and information on the time of the first 
symptoms, time of arrival to the first hospital and/
or PCi center, time of the first balloon insufflation 
during pPCi, affected myocardial wall and coronary 
artery, postprocedural flow, as well as on cardiogenic 
shock and lethal outcome were collected. Six months 
after discharge, data on major adverse cardiovas-
cular events (mACe) (angina pectoris, restenosis, 
reinfarction, re-PCi, mortality, coronary artery by-
pass graft and cerebrovascular accident rate) were 
collected for investigated patients during their ex-
amination, by checking medical documentation, or 
by telephone contact with the patient, patient family 
members, or home physicians. The investigation was 
performed between September 1, 2005 and novem-
ber 1, 2011. 
Cardiogenic shock was defined as a clinical state 
of hypoperfusion characterized by systolic blood 
pressure <90 mm hg and/or capillary wedge pressure 
>20 mm hg and/or cardiac index <1.80 L/min m2 [19-
21]. Total ischemic time or symptom onset-to-balloon 
time was calculated as the time between the first 
symptoms and balloon insufflations during primary 
PCi; door-to-balloon time, time between arrival to 
the first hospital (with or without on-site cath-lab) 
and balloon insufflations during primary PCi; and 
symptom onset-to-door time as the time between 
the first symptoms and arrival in the first hospital 
(with or without on-site cath-lab). Postprocedural 
flow was classified according to the Thrombolysis in 
myocardial infarction (Timi) grading system on 
the 0-3 scale22.
According to the 2011 census, the population of 
Croatia was 4 284 889, meaning that in the last phase 
(2010/2011) the Croatian pPCi network reached 
a rate of 454.9 pPCi/million inhabitants/year. The 
gross domestic product (GdP) in 2011 in Croatia was 
uS$ 13 99923.
Ethics
The investigation was performed in accordance 
with the ethical standards laid down in the declara-
tion of helsinki and was approved by the appropriate 
institutional review committees.
Statistics
nominal (categorical) variables were analyzed us-
ing Pearson χ2-test and Fisher exact test, and quan-
titative variables by mann-whitney test. differences 
between subgroups with elimination of influence of 
other variables were analyzed using multivariate log-
linear analysis. The value of p<0.05 was considered 
significant in all tests used. Statistical analysis was 
performed by using the Statistica 6.0 program. 
Results
during the three study intervals, the number of 
patients with acute STemi treated with pPCi per 
year was on a continuous increase (581 vs.1272 vs. 
1949 patients/year). descriptive statistics data and 
times to reperfusion in study patients in the three time 
intervals are shown in Table 1. The patient risk profile 
worsened during the study period, which was statisti-
cally significant for advancing age (60 vs. 61 vs. 63 
years; p<0.01), anterior myocardial wall involvement 
(43% vs. 44% vs. 51%; p<0.01) and shock rate (7% vs. 
9% vs. 11%; p<0.05), as well as for the percentage of 
transferred patients (42% vs. 36% vs. 46 %; p<0.01). 
during the study period, the door-to-balloon time 
was statistically significantly shortened (108 vs. 98 vs. 
75 min; p<0.01), whereas the symptom onset-to-door 
time was statistically significantly prolonged (130 vs. 
175 vs. 195 min; p<0.01). however, the authors found 
no statistically significant influence of the latter two 
changes on the total ischemic time. 
Patient treatment results accomplished in the three 
time intervals are shown in Table 2. univariate analy-
sis showed worsening of final Timi 3 flow (87% vs. 
82% vs. 85%; p<0.01), in-hospital mortality rate (4% 
vs. 5% vs. 8%; p<0.01), angina pectoris (12% vs. 22% 
vs. 36%; p<0.01) and other mACe in six-month fol-
low up (6% vs. 23% vs. 14%; p<0.01) during the study 
period. however, multivariate log-linear analysis used 
for elimination of the influence of higher risk profile 
on the results yielded significant differences only for 
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angina pectoris (p<0.01) and other mACe during 
follow up (p<0.01).
Discussion
According to the experience from countries with 
successful nationwide implementation of PCI in 
STemi, there are three realistic goals for pPCi net-
works at the national level: 1) pPCI should be used 
for >70% of all STemi patients; 2) pPCI rates should 
reach >600 per million inhabitants per year; and 3) the 
existing PCI centers should treat all their STemi pa-
tients by pPCI, i.e. should offer a 24/7 service3. The 
Table 1. Descriptive statistics data and times to reperfusion in the Croatian Primary Percutaneous Coronary Interven-
tion Network during the study period (three intervals)
variable 2005-2007 2008-2009 2010-2011 p
Age (yrs, median, range) 60 (24-95) 61 (21-95) 63 (26-92) <0.01**
Gender (m/F) 73.3%/26,7% 74.5%/25.5% 72.3%/27.7% 0.39*









non-transferred/transferred 57.8%/42.2% 64.4%/35.6% 53.6%/46.4% <0.01*
Cardiogenic shock 6.7% 8.8% 10.7% 0.01*
Symptom onset-to-door 
(median, range) 130 min (15-1365) 175 min (4-960) 195 min (10-1300) <0.01**
door-to-balloon (median, range) 108 min (10-540) 90 min (0-288) 75 min (4-432) <0.01**
Symptom onset-to-balloon 
(median, range) 265 min (45-702) 277 min (36-1102) 270 min (80-1595) 0.24**
LAd = left anterior descending coronary artery; ACx = circumflex coronary artery; RCA = right coronary artery; Lm = left main; 
symptom onset-to-door = time between first symptoms and arrival to the first hospital (with or without on-site cath-lab); door-to-
balloon = time between arrival to the first hospital (with or without on-site cath-lab) and balloon insufflations during primary PCi; 
symptom onset-to-balloon = time between first symptoms and balloon insufflations during primary PCi; *χ2-test; **kruskal-wallis 
AnovA by ranks
Table 2. Results of treatment in the Croatian Primary Percutaneous Coronary Intervention Network
variable 2005-2007 2008-2009 2010-2011 p* p**
Postprocedural Timi 3 flow 87.1% 82.1% 84.5% <0.01 0.85
mortality (in-hospital) 4.4% 4.9% 7.6% <0.01 0.37
mortality  (6-month follow up) 1.2% 1.9% 2.3% 0.41 0.76
Angina pectoris (6-month follow up) 12.1% 21.6% 36.0% <0.01 <0.01
mACe (other) (6-month follow up) 6.4% 23.2% 14.0% <0.01 <0.01
mACe (other) = major adverse cardiovascular events (restenosis, reinfarction, re-PCi, coronary artery by-pass graft and cerebrovascular 
accident); *χ2-test; **multivariate log-linear analysis
TARGeT study24, a multicenter, observational study 
that aimed to evaluate the epidemiological charac-
teristics, management pattern and outcome of acute 
coronary syndrome patients in Greece, revealed that 
invasive management was performed in only 40.2% 
of patients during index hospitalization, concluding 
that there remains considerable room for improve-
ment in expanding the implementation of invasive 
management in real world clinical practice. Compar-
ing the treatment of STemi patients between 2003 
and 2009, the Polish Registry10 showed that pPCi was 
performed in 51% and 78% of those patients, respec-
tively. investigating temporal trends in the treatment 
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of acute STemi, the authors from the uSA25 revealed 
an increase in pPCi and decrease in thrombolysis and 
coronary artery bypass grafting. The same trends be-
tween 2000 and 2007 have also been reported from 
Australia and new Zealand26 for STemi patients, 
reaching an increase in emergency revascularization 
with pPCi (from 11% to 27%) and in-hospital coro-
nary angiography (from 61% to 76%). despite the fact 
that the Croatian GdP is lower in comparison with 
the most developed countries, an increasing trend and 
a relatively high rate of STemi patients treated with 
pPCi were found in this investigation. it is the conse-
quence of the enthusiastic work of Croatian cardiolo-
gists to make the problem recognized among health 
authorities and other stakeholders. Also, it has en-
abled the Croatian pPCi network results to approach 
the goals set at the beginning of this article.
The increasing age and percentage of female gen-
der among STemi patients over time, identified in 
the present study, have also been reported in other 
studies from different parts of the world7,10,12. These 
groups of patients have a higher risk of developing se-
rious mortality predictors, i.e. cardiogenic shock and 
heart failure27. The increasing trend in the percentage 
of transferred patients, also recorded in our study, may 
have unfavorable effect on treatment results, but not 
according to all authors28-30. 
delay to reperfusion in STemi patients is associ-
ated with a higher risk of mortality31,32. in the Polish 
Registry10, delay to reperfusion tended to reduce over 
time, which is probably one of the reasons for decrease 
in the proportion of patients presenting with pulmo-
nary edema or cardiogenic shock in this registry. on 
the other hand, the longer symptom onset-to-door 
time in the Croatian pPCi network over time could 
be one of the reasons for a different trend of increase in 
the proportion of STemi patients treated with pPCi 
in cardiogenic shock. The reperfusion times recorded 
in this study, the door-to-balloon time in particu-
lar, were within the limits reported by most of other 
authors1,10,29,34. however, the trend of the door-to-bal-
loon time shortening found here was not enough to 
lower the mortality rate in STemi, as reported from 
several studies29,30,33-35. The lack of shortening of the 
more important total ischemic time because of ex-
tended prehospital delay in Croatian patients should 
stimulate additional actions (media campaign, educa-
tion of out-of-hospital medical staff, continuous qual-
ity control, etc.) at the local and national level. Ladwig 
et al.36, who report a constantly high prehospital delay 
in STemi patients from the Augsburg myocardial 
infarction Registry over a 20-year observation period, 
emphasize a subgroup of elderly women as a target for 
improvement of this parameter. Finally, results from 
the miTRAplus and oPTAmi registry proved that 
prehospital delay could be an independent predictor of 
a longer door-to-balloon time33.
As in the first phase investigation of the Croa-
tian pPCi network14,15, the postprocedural Timi 
3 flow and in-hospital mortality rate, as well as the 
mortality and other mACe rate during six-month 
follow up recorded in this study are comparable with 
recent results from other pPCi networks10,13,26,29,37,38. 
most of the latest studies report on decreasing trends 
in mortality and other complication rates. on the 
other hand, there are studies reporting results that 
remained stable over time11,35,39. it should be noted 
that these results depend very much on the risk pro-
file of study patients. in the present investigation, 
worsening of the patient risk profile during the study 
period was the main reason why the final Timi 3 
flow, in-hospital mortality, and six-month mortality 
rate did not change significantly. Also, according to 
the literature3,18,19, less experienced low volume PCi 
centers could have worse results in the interventional 
STemi treatment in comparison with high-volume 
centers. however, a higher patient risk profile and 
new PCi centers in the Croatian pPCi network 
ensure treatment of acute STemi for clinically 
and geographically wider groups of patients, which 
should be understood as a positive trend. Some of the 
reasons for the trend of significant increase in the rate 
of angina pectoris and other mACe during follow 
up could be found in changes in the strategy of pPCi 
during the study period (pPCi of the culprit lesion 
only) and higher availability of PCi centers for addi-
tional PCi during follow up after acute STemi. 
in conclusion, the Croatian pPCi network con-
tinuously ensures very good results of treatment for 
ever greater number of STemi patients despite wors-
ening of their risk profile and opening of new, less ex-
perienced PCi centers. This study has confirmed that 
there is room for improvement, especially in shorten-
ing prehospital delay.
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Sažetak
SedmoGodiŠnJi TRendovi u ReZuLTATimA hRvATSke mReŽe PRimARne PeRkuTAne 
koRonARne inTeRvenCiJe
Z. Babić, H. Pintarić, B. Starčević, J. Bulum, V. Tomulić, L. Giunio, I. Vuković, R. Steiner, H. Stipić, J. Šikić, D. Zekanović, 
D. Prvulović, D. Kozmar i D. Miličić
Autori su istražili trendove u rezultatima hrvatske mreže primarne perkutane koronarne intervencije (primary percu-
taneous coronary intervention, pPCi) između tri razdoblja (2005.-2007. (prva faza), 2008.-2009. (druga faza), 2010.-2011. 
(treća faza)). Prikupljeni su i izračunati podaci o 5650 bolesnika s akutnim infarktom sa ST-elevacijom (STemi) tran-
sportiranih ili izravno zaprimljenih i liječenih pomoću pPCi u 11 hrvatskih PCi centara tijekom toga vremena.Godišnji 
broj bolesnika s akutnim STemi liječenih pomoću pPCi kontinuirano je rastao tijekom istraživanog vremena (581 prema 
1272 prema 1949 bolesnika/godina). Rizični profil bolesnika se pogoršao kroz istraživano vrijeme: dob (60 prema 61 prema 
63 godine; p<0,01), zahvaćanje prednje miokardijalne stijenke (43% prema 44% prema 51%; p<0,01), udio šoka (7% prema 
9% prema 11%; p<0,05), postotak transportiranih bolesnika (42% prema 36% prema 46%; p<0,01). dok se vrijeme od 
dolaska u bolnicu do uvođenja balona skraćivalo (108 prema 98 prema 75 min; p<0,01), vrijeme od nastupa simptoma do 
dolaska u bolnicu se produžavalo (130 prema 175 prema 195 min; p<0,01), ali bez statistički značajnog utjecaja na ukupno 
vrijeme ishemije. multivarijatna log-linearna analiza, eliminirajući utjecaj višeg rizičnog profila na rezultate liječenja, nije 
pronašla statistički značajne promjene u završnom protoku Timi 3 (Thrombolysis In Myocardial Infarction 3), bolničkom po-
bolu i smrtnosti tijekom šest mjeseci, ali je pokazala značajan porast učestalosti pektoralne angine (12% prema 22% prema 
36%; p<0,01) i drugih velikih nepovoljnih kardiovaskularnih događaja (major adverse cardiovascular events, mACe) (6% 
prema 23% prema 14%; p<0,01) za vrijeme praćenja. Zaključno, hrvatska mreža pPCi kontinuirano osigurava vrlo dobre 
rezultate liječenja STemi u ovoj slabije razvijenoj zapadnoj zemlji unatoč pogoršanju rizičnog profila liječenih bolesnika, 
kao i otvaranju novih i manje iskusnih PCi centara. Povećanje postotka mACe može se objasniti promjenama u strategiji 
pPCi tijekom vremena (pPCi samo za ciljne lezije) i većom dostupnošću PCi centara za dodatnu PCi tijekom praćenja 
nakon akutnog STemi. ipak ima prostora za poboljšanje, osobito u skraćenju predbolničkog kašnjenja.
ključne riječi: Srčani infarkt – terapija; Koronarna bolest – terapija; Perkutana koronarna intervencija; Hrvatska 
